Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen™ Micro-Interventional Cyclodialysis System Procedures in Patients With Open Angle Glaucoma

NCT05506423 is registered in ClinicalTrials.gov with Iantrek, Inc. as lead sponsor.

NCT NCT05506423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05506423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Registry Study of Safety and Effectiveness Outcomes Through 24 Months Postoperatively Following CycloPen™ Micro-Interventional Cyclodialysis System Procedures in Patients With Open Angle Glaucoma
Lead sponsor
Iantrek, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
August 17, 2022
Completion date
December 31, 2027
Enrollment
300 (estimated)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

open angle glaucoma